Announcements Trials
Browse Landscape

Status

Recruiting 4Unknown 3Completed 3Withdrawn 2Not yet recruiting 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 34Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Blood Specimen Collection 17Surveys and Questionnaires 14Psychiatric Rehabilitation 7Therapeutics 6Polymerase Chain Reaction 5Interviews as Topic 5Immunohistochemistry 5Gene Expression Profiling 5Biopsy 5Radiotherapy 4Magnetic Resonance Spectroscopy 4High-Energy Shock Waves 4Reverse Transcriptase Polymerase Chain Reaction 3Microarray Analysis 3Fluorodeoxyglucose F18 3Abiraterone Acetate 3Watchful Waiting 2Standard of Care 2Specimen Handling 2Prednisone 2Methods 2Leuprolide 2In Situ Hybridization, Fluorescence 2Hematologic Tests 2Glucose Tolerance Test 2Drug Therapy 2Comparative Genomic Hybridization 2Chemotherapy, Adjuvant 2Biopsy, Fine-Needle 2Bariatric Surgery 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Observational × Prednisone × Clear all
NCT00900445 2018-08-07

Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia

Children's Oncology Group

Withdrawn
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01692483 2015-12-02

Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Janssen Pharmaceutica

Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡